Cite

1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386-93.10.1182/blood-2008-07-16250319005182Search in Google Scholar

2. Kurien B, Hensley K, Bachmann M, Scofield R. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med. 2006;41(4):549-56.10.1016/j.freeradbiomed.2006.05.02016863987Search in Google Scholar

3. Griffiths H. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease. Autoimmun Rev. 2008;7(7):544-49.10.1016/j.autrev.2008.04.01318625443Search in Google Scholar

4. Filippin L, R.Vercelino, Marroni N, Xavier R. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. 2008;152:415-22.10.1111/j.1365-2249.2008.03634.x245319618422737Search in Google Scholar

5. Hassan S, Gheita T, Kenawy S, Fahim A, El- Sorougy I, Abdou M. Oxidative stress in systemic lupus erythematosus and rheumatoid arthritis patients: relationship to disease manifestations and activity. Int J Rheum Dis. 2011;14(4): 325-31.10.1111/j.1756-185X.2011.01630.x22004228Search in Google Scholar

6. Mansour B, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, et al. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol. 2010;39(3):247-53.10.3109/0300974090336251120429675Search in Google Scholar

7. Kurien B, Scofield R. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev. 2008;7(7):567-73.10.1016/j.autrev.2008.04.019258503718625446Search in Google Scholar

8. Matsuuraa E, Hughes G, Khamashta M. Oxidation of LDLand its clinical implication Autoimmun Rev. 2008;7(7):558-66.Search in Google Scholar

9. Filippin L, Vercelino R, Marroni N, Xavier R. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol. 2008;152:415-22.10.1111/j.1365-2249.2008.03634.xSearch in Google Scholar

10. Elsalakawy W, Ali M, Hegazy M, Farweez B. Value of vanin-1 assessment in adult patients with primary immune thrombocytopenia. Platelets. 2014;25(2):86-92.10.3109/09537104.2013.78248423534352Search in Google Scholar

11. Zhang B, Lo C, Shen L, Sood R, Jones C, Cusmano-Ozog K, et al. The role of vanin-1 and oxidative stress-related pathways in distinguishing acute and chronic pediatric ITP. Blood. 2011;117:4569-79.10.1182/blood-2010-09-30493121325602Search in Google Scholar

12. Cines D. Pathogenesis of ITP. In: Cines D, Kuter D, Newland A, Provan D, Semple J, editors. The Handbook-Immune Thrombocytopenia. 1st ed. Genoa: European School of Haematology; 2011. p. 77-87.Search in Google Scholar

13. Cines D, Bussel J, Liebman H, Luning P. The ITPsyndrome: Pathogenic and clinical diversity. Blood. 2009;113:6511-21.10.1182/blood-2009-01-129155271091319395674Search in Google Scholar

14. Kamhieh-Milz J, Bal G, Sterzer V, Kamhieh-Milz S, Arbach O, Salama A. Reduced antioxidant capacities in platelets from patients with autoimmune thrombocytopenia purpura (ITP). Platelets. 2012;23:184-94.10.3109/09537104.2011.61090921913810Search in Google Scholar

15. Jin CQ, Dong HX, Cheng PP, Zhou JW, Zheng BY, Liu F. Antioxidant status and oxidative stress in patients with chronic ITP. Scand J Immunol. 2013;77:482-7.10.1111/sji.1204823551069Search in Google Scholar

16. Akbayram S, Dogan M, Akgun C, Mukul Y, Peker E, Bay A, et al. The association of oxidant status and antioxidant capacity in children with acute and chronic ITP. J Pediatr Hematol Oncol. 2010;32(4):277-81.10.1097/MPH.0b013e3181d6421f20404751Search in Google Scholar

17. Polat G,Tamer L,Tanriverdi K, Gurkan E, Baslamisli F, Atik U. Levels of malondialdehyde, glutathione and ascorbic acid in idiopathic thrombocytopaenic purpura. East Afr Med J. 2002;79(8):446-9.10.4314/eamj.v79i8.883312638848Search in Google Scholar

18. Kamhieh-Milz J, Salama A. Oxidative stress is predominant in female but not in male patients with autoimmune thrombocytopenia. Oxid Med Cell Longev. 2014;2014:720347. 10.1155/2014/720347394160224688630Search in Google Scholar

eISSN:
1313-9053
Language:
English
Publication timeframe:
2 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Ophthalmology, Public Health, Pharmacy, Clinical Pharmacy